Canada markets open in 4 hours 15 minutes

Syros Pharmaceuticals, Inc. (0S90.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
3.7100+0.0700 (+1.92%)
As of 08:02AM CEST. Market open.
Full screen
Previous Close3.6400
Bid3.7100 x N/A
Ask3.8700 x N/A
Day's Range3.7100 - 3.7100
52 Week Range2.3000 - 6.7300
Avg. Volume1
Market Cap77.066M
Beta (5Y Monthly)1.58
PE Ratio (TTM)N/A
EPS (TTM)-0.2300
Earnings DateNov 13, 2023 - Nov 17, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    CAMBRIDGE, Mass., September 07, 2023--Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced the grant of restricted stock unit (RSU) awards for an aggregate of 20,650 shares of Syros common stock to two newly hired employees in connection with commencing employment with Syros. These RSUs were granted as a material inducement to employment in accordance with Nasdaq List

  • Thomson Reuters StreetEvents

    Q2 2023 Syros Pharmaceuticals Inc Earnings Call

    Q2 2023 Syros Pharmaceuticals Inc Earnings Call

  • Zacks

    Syros Pharmaceuticals, Inc. (SYRS) Reports Q2 Loss, Lags Revenue Estimates

    Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -17.12% and 10.52%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?